Details for New Drug Application (NDA): 090712
✉ Email this page to a colleague
NDA 090712 describes POLYETHYLENE GLYCOL 3350 AND ELECTROLYTES, which is a drug marketed by Paddock Llc and Strides Pharma and is included in two NDAs. It is available from one supplier. Additional details are available on the POLYETHYLENE GLYCOL 3350 AND ELECTROLYTES profile page.
The generic ingredient in POLYETHYLENE GLYCOL 3350 AND ELECTROLYTES is polyethylene glycol 3350; potassium chloride; sodium bicarbonate; sodium chloride; sodium sulfate anhydrous. There are four hundred and twenty-one drug master file entries for this compound. Six suppliers are listed for this compound. Additional details are available on the polyethylene glycol 3350; potassium chloride; sodium bicarbonate; sodium chloride; sodium sulfate anhydrous profile page.
The generic ingredient in POLYETHYLENE GLYCOL 3350 AND ELECTROLYTES is polyethylene glycol 3350; potassium chloride; sodium bicarbonate; sodium chloride; sodium sulfate anhydrous. There are four hundred and twenty-one drug master file entries for this compound. Six suppliers are listed for this compound. Additional details are available on the polyethylene glycol 3350; potassium chloride; sodium bicarbonate; sodium chloride; sodium sulfate anhydrous profile page.
Summary for 090712
| Tradename: | POLYETHYLENE GLYCOL 3350 AND ELECTROLYTES |
| Applicant: | Paddock Llc |
| Ingredient: | polyethylene glycol 3350; potassium chloride; sodium bicarbonate; sodium chloride; sodium sulfate anhydrous |
| Patents: | 0 |
Profile for product number 001
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | FOR SOLUTION;ORAL | Strength | 240GM/BOT;2.98GM/BOT;6.72GM/BOT;5.84GM/BOT;22.72GM/BOT | ||||
| Approval Date: | Feb 25, 2010 | TE: | RLD: | No | |||||
Complete Access Available with Subscription
